37
Deep Track Biotechnology Fund, LP updates its Form D — $842M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $842M · GREENWICH, CT · filed 2026-04-01
3(c)(7) — qualified purchasers
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
| Nir Messafi | Chief Operating and Financial Officer and Chief Compliance Officer of the GP |
| n/a Deep Track Biotechnology Fund GP, LLC | "General Partner of the Issuer (the ""GP"")" |
| David Kroin | Chief Investment Officer of the GP |
Signed by Nir Messafi, Chief Operating & Financial Officer & CCO of the GP.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.